Weight loss achieved through GLP-1 drugs can improve blood sugar control, reduce inflammation and enhance insulin sensitivity, factors that may positively influence reproductive function
Chemiluminescence in semen of infertile men
Seijas-Amigo J, Salgado-Barreira , Castelo-Domnguez R, Pereira-Pa M, Rodrguez-Maero M, Gonzlez-Juanatey JR (2022) Semaglutide versus GLP-1 agonists
Market Opportunities Biosimilar Liraglutide Access Markets, Emerging Geography Expansion, and Precision Obesity Medicine Unlock Underserved GLP-1 Market Growth Segments Biosimilar liraglutide entry represents the first generic competition wave for the GLP-1 weight loss drug category, expanding access for the 480 million obesity patients in lower-middle income countries for whom USD 1,000-plus monthly branded drug pricing is permanently inaccessible
Missed cholelithiasis may be complicated with deleterious consequences in patients with T2D